Get started
Author

Fabio Valente

Observed names: F Valente, F. Valente, Fabio VALENTE
Institution: Ospedale Monaldi
Observed institutions: University of Campania "Luigi Vanvitelli", Erasmus Hospital, European Society of Cardiology, ASL Roma, Associazione Nazionale Medici Cardiologi Ospedalieri, Ospedale Monaldi, Azienda Sanitaria Locale Roma 3
ORCID: 0009-0006-5647-061X
Observed ORCID: 0009-0006-5647-061X
OpenAlex ID: A5086578220
Pediatric Heart Failure: A Practical Guide to Diagnosis and Management
2017 · Daniele Masarone, Fabio Valente, et al. · Pediatrics & Neonatology · 139
PDF
Management of Arrhythmias in Heart Failure
2017 · Daniele Masarone, Giuseppe Limongelli, et al. · Journal of Cardiovascular Development and Disease · 92
PDF
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy
2016 · Damiano Magrì, Giuseppe Limongelli, et al. · Heart · 67
Heart Failure Progression in Hypertrophic Cardiomyopathy – Possible Insights From Cardiopulmonary Exercise Testing –
2016 · Damiano Magrì, Federica Re, et al. · Circulation Journal · 66
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
2024 · Juan Pablo Kaski, Gabrielle Norrish, et al. · European Heart Journal · 64
PDF
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
2022 · Luis R Lopes, Maria-Angela Losi, et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 51
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry
2024 · Alida L P Caforio, Juan P Kaski, et al. · European Heart Journal · 43
PDF
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy
2018 · Damiano Magri, Piergiuseppe Agostoni, et al. · International Journal of Cardiology · 36
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism
2019 · Augusto Esposito, Emanuele Monda, et al. · European Journal of Preventive Cardiology · 24
The Role of Echocardiography in the Management of Heart Transplant Recipients
2021 · Daniele Masarone, Michelle Kittleson, et al. · Diagnostics · 23
PDF
Effects of Sacubitril/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction
2020 · Daniele Masarone, Vittoria Errigo, et al. · Journal of Clinical Medicine · 23
PDF
Pick Your Threshold
2022 · Elisabetta Salvioni, Massimo Mapelli, et al. · CHEST Journal · 20
PDF
Pathophysiology-Based Management of Acute Heart Failure
2023 · Luigi Falco, Maria Luigia Martucci, et al. · Clinics and Practice · 18
PDF
How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice
2023 · Daniele Masarone, Brian Houston, et al. · Journal of Clinical Medicine · 15
PDF
Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
2023 · Luigi Falco, Benedetta Brescia, et al. · Journal of Cardiovascular Development and Disease · 14
PDF
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis
2021 · Enrico Melillo, Daniele Masarone, et al. · Heart Failure Clinics · 13
Exercise‐based rehabilitation strategies in heart transplant recipients: Focus on high‐intensity interval training
2020 · Daniele Masarone, Enrico Melillo, et al. · Clinical Transplantation · 13
PDF
Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a real-world experience
2020 · Daniele Masarone, Fabio Valente, et al. · Journal of Cardiovascular Medicine · 13
Clinical relevance of transient worsening renal function after initiation of sacubitril/valsartan
2020 · Daniele Masarone, Enrico Melillo, et al. · Current Medical Research and Opinion · 12
Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
2022 · Daniele Masarone, Michelle M. Kittleson, et al. · Journal of Clinical Medicine · 11
PDF
Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy
2021 · Giovanna Gallo, Vittoria Mastromarino, et al. · Biomolecules · 9
PDF
Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow?
2024 · Daniele Masarone, Fabio Valente, et al. · Journal of Clinical Medicine · 7
PDF
Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report
2022 · Daniele Masarone, Andrea Petraio, et al. · Frontiers in Cardiovascular Medicine · 5
PDF
Molecular Basis and Clinical Management of Pompe Disease
2013 · Giancarlo Parenti, Giuseppe Di Iorio, et al. · Cardiogenetics · 5
Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
2019 · Daniele Masarone, Marina Verrengia, et al. · Medical Sciences · 4
PDF
Works count: 39
Citation count: 804
H-index: 14
I10-index: 20
Year
Topic
Type